Increased genetic susceptibility to intestinal‐type gastric cancer is associated with increased activity of the RUNX3 distal promoter
Authors:
- Hyoungseok JuHJHyoungseok Ju
- Minjin KimMKMinjin Kim
- Changwon KangCKChangwon Kang
Open Access
Abstract
BACKGROUND: The runt‐related transcription factor RUNX3 plays essential roles in various types of tumors, including gastric cancer. Epigenetic changes in the methylation of the RUNX3 proximal promoter, but not common genetic changes in RUNX3, have been associated with both changes in the gene expression and development of the cancer.METHODS: A case‐control association study was conducted by genotyping 865 unrelated Korean subjects. Subsequent functional studies were performed to reveal functional implication of genetic association.RESULTS: Several single‐nucleotide polymorphisms (SNPs) in RUNX3 were significantly associated with susceptibility to intestinal‐type gastric cancer (.0028 ≤ P ≤ .022) but not diffuse‐type gastric cancer (.70 ≤ P ≤ .96). The risk‐associated, minor variant of an intestinal‐type gastric cancer‐associated SNP in the RUNX3 distal promoter (rs7528484) significantly increased promoter activity in a CREB1‐dependent manner. The distal promoter‐derived, 33 kDa isoform of RUNX3 increased the activity of transcription factor nuclear factor kappa B (NF‐κB), which had been activated by Helicobacter pylori infection, a risk factor for intestinal‐type gastric cancer, and the expression of the interleukin‐1β gene (IL1B), an NF‐κB target genetically and functionally associated with gastric cancer. In contrast, the proximal promoter‐derived, 44 kDa isoform of RUNX3 decreased both NF‐κB activity and IL1B expression.CONCLUSIONS: In addition to epigenetic changes in the RUNX3 proximal promoter, genetic changes in the distal promoter may be associated with susceptibility to intestinal‐type gastric cancer by increasing promoter activity. Functionally, 2 RUNX3 isoforms may contribute differentially to intestinal‐type gastric cancer susceptibility, at least in part through regulating NF‐κB activity and IL1B expression Cancer 2011;. © 2011 American Cancer Society.Keywords
This publication has 33 references indexed in Scilit:
- The novel RUNX3/p33 isoform is induced upon monocyte-derived dendritic cell maturation and downregulates IL-8 expressionImmunobiology, 2010
- Genetic variants in the Runt‐related transcription factor 3 gene contribute to gastric cancer risk in a Chinese populationCancer Science, 2009
- Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer CellsCancer Research, 2008
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in MiceCancer Cell, 2008
- Inhibition of NF-κB Acetylation and its Transcriptional Activity by DaxxJournal of Molecular Biology, 2007
- Pattern of Transcription Factor Activation in Helicobacter pylori–Infected Mongolian GerbilsGastroenterology, 2007
- Inflammation, atrophy, and gastric cancerJournal of Clinical Investigation, 2007
- RUNX3 Suppresses Gastric Epithelial Cell Growth by Inducing p21WAF1/Cip1 Expression in Cooperation with Transforming Growth Factor β-Activated SMADMolecular and Cellular Biology, 2005
- Runx3−/− gastric epithelial cells differentiate into intestinal type cellsBiochemical and Biophysical Research Communications, 2004
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000